BiotechTube
Home/Grace Science/Matt Wilsey
MW

Matt Wilsey

Co-founder and CEO

Grace Science

Therapeutic Areas

Rare Genetic DiseaseOncologyNeurodegenerative Diseases

Grace Science Pipeline

DrugIndicationPhase
Gene therapy programNGLY1 DeficiencyPre-clinical
Oncology ProgramUndisclosed CancersDiscovery/Pre-clinical
NEURODEGENERATION programUndisclosed Neurodegenerative DiseasesDiscovery/Pre-clinical

Leadership Team at Grace Science

DC
Dr. Carolyn Bertozzi
Co-founder, Nobel Laureate, Stanford Professor
View full Grace Science profile